Search Results for 'car t therapies'
-
Biologics, Proteins, Vaccines | Cold Chain Management | Drug Development | Supply Chain
CAR T for Large Tumors: The Next Frontier?
Ryan Carpentier of Cryoport discusses the successes and the challenges these exciting new therapies presentRyan Carpentier, Executive Director of Business Development at Cryoport 09.10.19
-
Bio News | Breaking News | Clinical Trials | Collaborations & Alliances | Drug Development | Industry News
Servier, Allogene Expand Clinical CAR T Tie-up
Announces FDA clearance of the IND for ALLO-501, an anti-CD19 Allogeneic CAR T therapy01.28.19
-
Breaking News | Promotions & Moves
Mustang Bio Appoints CMO
Dr. Sersch brings more than 17 years of experience in early- and late-stage clinical development10.17.18
-
Bio News | Industry News | Logistics | Packaging & Tracking | Supply Chain
TrakCel, Mustang Ink Supply Chain Deal
Companies aim to build a custom-configured cellular supply chain tracking and orchestration platform07.19.18
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Industry News
CrownBio Expands CAR T-Cell Therapy Platform
The expansion focuses on new bioluminescent imaging capabilities02.20.18
-
Bio News | Biologics, Proteins, Vaccines | Collaborations & Alliances | Industry News
Juno, Thermo Fisher Announce CAR T Manufacturing Partnership
The partnership is in the form of a seven-year nonexclusive licensing and supply agreement12.20.17
-
Collaborations & Alliances | Industry News | R&D
Mustang Bio Inks Cancer Pacts
Forms license agreement with Harvard; enters research collaboration with Beth Israel Deaconess Medical Center12.04.17
-
Cold Chain Management | Logistics | Supply Chain
CAR-T Supply Chain Logistics
Processes and technologies associated with supporting logistics for the first FDA-approved CAR-T therapiesOnline Exclusives Kristin Brooks, Contract Pharma 11.06.17
-
Biologics, Proteins, Vaccines | cGMP Manufacture | Industry News
Mustang Bio Establishes CAR T Cell Therapy Mfg. Facility
Facility in UMass Medicine Science Park will support clinical development and commercialization of CAR T pipeline10.30.17
-
Biologics, Proteins, Vaccines | Collaborations & Alliances | Drug Development | Drug Discovery
Baxalta, Precision BioSciences in Immuno-oncology Alliance
Aims to develop CAR T cell therapies for areas of unmet need in multiple cancers02.25.16
